Neuropace, Inc.

Q3 2023 13F Holders

Symbol
NPCE
CUSIP
641288105
Type
Equity
Class
COM
Num filings
26
Total reported value, excl. options
$176 M
Manager Report Date Value ($000) Shares Option Type